Docoh
Loading...

Mardi Dier

Mardi Dier is CFO & Executive Vice President of Ultragenyx Pharmaceutical Inc.

Person profile

Roles
Ultragenyx Pharmaceutical CFO & Executive Vice President
Address
South San Francisco, California
Employees
SEC CIK

Calendar

24 Jan 22
Date Company Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
14 Oct 21 RARE Ultragenyx Pharmaceutical Common Stock Sell Dispose S No Yes 81.16 3,261 264.66K 38,762
12 Oct 21 RARE Ultragenyx Pharmaceutical Common Stock Sell Dispose S No No 82.79 3,477 287.86K 42,023
18 Jun 21 PRLD Prelude Therapeutics Director Stock Option Common Stock Grant Acquire A No No 31.02 23,344 724.13K 23,344
16 Jun 21 ORIC ORIC Pharmaceuticals Stock Option Common Stock Grant Acquire A No No 19.03 16,625 316.37K 16,625
2 Jun 21 ADMS Adamas Pharmaceuticals Common Stock Grant Acquire A No No 0 5,000 0 10,000
2 Jun 21 ADMS Adamas Pharmaceuticals Stock Option Common Stock Grant Acquire A No No 5.21 10,000 52.1K 10,000
1 Mar 21 RARE Ultragenyx Pharmaceutical Common Stock Grant Acquire A No No 0 5,500 0 45,500
1 Mar 21 RARE Ultragenyx Pharmaceutical Stock Option Common Stock Grant Acquire A No No 142.47 11,000 1.57M 11,000

Financial reports

No filings

Current reports

No filings

Registration and prospectus

No filings

Proxies

No filings

Other

No filings